Global Gene Editing Service Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Gene Editing Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Gene Editing Service market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Commercial accounting for % of the Gene Editing Service global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ex-Vivo segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gene Editing Service include Caribou Biosciences, CRISPR Therapeutics, Merck KGaA, Editas Medicine, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gene Editing Service market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ex-Vivo
In-Vivo
Market segment by Application, can be divided into
Commercial
Academic Research
Market segment by players, this report covers
Caribou Biosciences
CRISPR Therapeutics
Merck KGaA
Editas Medicine
Thermo Fisher Scientific
Horizon Discovery
Genscript Biotech
GeneCopoeia
Integrated DNA Technologies
Eurofins Genomics
DNA 2.0 (ATUM)
BBI Life Sciences
Genewiz
Gene Oracle
SBS Genetech
Bio Basic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gene Editing Service product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Editing Service, with revenue, gross margin and global market share of Gene Editing Service from 2019 to 2022.
Chapter 3, the Gene Editing Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gene Editing Service market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gene Editing Service research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Gene Editing Service
1.2 Classification of Gene Editing Service by Type
1.2.1 Overview: Global Gene Editing Service Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gene Editing Service Revenue Market Share by Type in 2021
1.2.3 Ex-Vivo
1.2.4 In-Vivo
1.3 Global Gene Editing Service Market by Application
1.3.1 Overview: Global Gene Editing Service Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Commercial
1.3.3 Academic Research
1.4 Global Gene Editing Service Market Size & Forecast
1.5 Global Gene Editing Service Market Size and Forecast by Region
1.5.1 Global Gene Editing Service Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gene Editing Service Market Size by Region, (2017-2022)
1.5.3 North America Gene Editing Service Market Size and Prospect (2017-2028)
1.5.4 Europe Gene Editing Service Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gene Editing Service Market Size and Prospect (2017-2028)
1.5.6 South America Gene Editing Service Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gene Editing Service Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Editing Service Market Drivers
1.6.2 Gene Editing Service Market Restraints
1.6.3 Gene Editing Service Trends Analysis
2 Company Profiles
2.1 Caribou Biosciences
2.1.1 Caribou Biosciences Details
2.1.2 Caribou Biosciences Major Business
2.1.3 Caribou Biosciences Gene Editing Service Product and Solutions
2.1.4 Caribou Biosciences Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Caribou Biosciences Recent Developments and Future Plans
2.2 CRISPR Therapeutics
2.2.1 CRISPR Therapeutics Details
2.2.2 CRISPR Therapeutics Major Business
2.2.3 CRISPR Therapeutics Gene Editing Service Product and Solutions
2.2.4 CRISPR Therapeutics Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 CRISPR Therapeutics Recent Developments and Future Plans
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA Gene Editing Service Product and Solutions
2.3.4 Merck KGaA Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Merck KGaA Recent Developments and Future Plans
2.4 Editas Medicine
2.4.1 Editas Medicine Details
2.4.2 Editas Medicine Major Business
2.4.3 Editas Medicine Gene Editing Service Product and Solutions
2.4.4 Editas Medicine Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Editas Medicine Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Gene Editing Service Product and Solutions
2.5.4 Thermo Fisher Scientific Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Horizon Discovery
2.6.1 Horizon Discovery Details
2.6.2 Horizon Discovery Major Business
2.6.3 Horizon Discovery Gene Editing Service Product and Solutions
2.6.4 Horizon Discovery Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Horizon Discovery Recent Developments and Future Plans
2.7 Genscript Biotech
2.7.1 Genscript Biotech Details
2.7.2 Genscript Biotech Major Business
2.7.3 Genscript Biotech Gene Editing Service Product and Solutions
2.7.4 Genscript Biotech Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Genscript Biotech Recent Developments and Future Plans
2.8 GeneCopoeia
2.8.1 GeneCopoeia Details
2.8.2 GeneCopoeia Major Business
2.8.3 GeneCopoeia Gene Editing Service Product and Solutions
2.8.4 GeneCopoeia Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 GeneCopoeia Recent Developments and Future Plans
2.9 Integrated DNA Technologies
2.9.1 Integrated DNA Technologies Details
2.9.2 Integrated DNA Technologies Major Business
2.9.3 Integrated DNA Technologies Gene Editing Service Product and Solutions
2.9.4 Integrated DNA Technologies Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Integrated DNA Technologies Recent Developments and Future Plans
2.10 Eurofins Genomics
2.10.1 Eurofins Genomics Details
2.10.2 Eurofins Genomics Major Business
2.10.3 Eurofins Genomics Gene Editing Service Product and Solutions
2.10.4 Eurofins Genomics Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Eurofins Genomics Recent Developments and Future Plans
2.11 DNA 2.0 (ATUM)
2.11.1 DNA 2.0 (ATUM) Details
2.11.2 DNA 2.0 (ATUM) Major Business
2.11.3 DNA 2.0 (ATUM) Gene Editing Service Product and Solutions
2.11.4 DNA 2.0 (ATUM) Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 DNA 2.0 (ATUM) Recent Developments and Future Plans
2.12 BBI Life Sciences
2.12.1 BBI Life Sciences Details
2.12.2 BBI Life Sciences Major Business
2.12.3 BBI Life Sciences Gene Editing Service Product and Solutions
2.12.4 BBI Life Sciences Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 BBI Life Sciences Recent Developments and Future Plans
2.13 Genewiz
2.13.1 Genewiz Details
2.13.2 Genewiz Major Business
2.13.3 Genewiz Gene Editing Service Product and Solutions
2.13.4 Genewiz Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Genewiz Recent Developments and Future Plans
2.14 Gene Oracle
2.14.1 Gene Oracle Details
2.14.2 Gene Oracle Major Business
2.14.3 Gene Oracle Gene Editing Service Product and Solutions
2.14.4 Gene Oracle Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Gene Oracle Recent Developments and Future Plans
2.15 SBS Genetech
2.15.1 SBS Genetech Details
2.15.2 SBS Genetech Major Business
2.15.3 SBS Genetech Gene Editing Service Product and Solutions
2.15.4 SBS Genetech Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 SBS Genetech Recent Developments and Future Plans
2.16 Bio Basic
2.16.1 Bio Basic Details
2.16.2 Bio Basic Major Business
2.16.3 Bio Basic Gene Editing Service Product and Solutions
2.16.4 Bio Basic Gene Editing Service Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Bio Basic Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Editing Service Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Editing Service Players Market Share in 2021
3.2.2 Top 10 Gene Editing Service Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gene Editing Service Players Head Office, Products and Services Provided
3.4 Gene Editing Service Mergers & Acquisitions
3.5 Gene Editing Service New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gene Editing Service Revenue and Market Share by Type (2017-2022)
4.2 Global Gene Editing Service Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Gene Editing Service Revenue Market Share by Application (2017-2022)
5.2 Global Gene Editing Service Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Gene Editing Service Revenue by Type (2017-2028)
6.2 North America Gene Editing Service Revenue by Application (2017-2028)
6.3 North America Gene Editing Service Market Size by Country
6.3.1 North America Gene Editing Service Revenue by Country (2017-2028)
6.3.2 United States Gene Editing Service Market Size and Forecast (2017-2028)
6.3.3 Canada Gene Editing Service Market Size and Forecast (2017-2028)
6.3.4 Mexico Gene Editing Service Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Editing Service Revenue by Type (2017-2028)
7.2 Europe Gene Editing Service Revenue by Application (2017-2028)
7.3 Europe Gene Editing Service Market Size by Country
7.3.1 Europe Gene Editing Service Revenue by Country (2017-2028)
7.3.2 Germany Gene Editing Service Market Size and Forecast (2017-2028)
7.3.3 France Gene Editing Service Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gene Editing Service Market Size and Forecast (2017-2028)
7.3.5 Russia Gene Editing Service Market Size and Forecast (2017-2028)
7.3.6 Italy Gene Editing Service Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Editing Service Revenue by Type (2017-2028)
8.2 Asia-Pacific Gene Editing Service Revenue by Application (2017-2028)
8.3 Asia-Pacific Gene Editing Service Market Size by Region
8.3.1 Asia-Pacific Gene Editing Service Revenue by Region (2017-2028)
8.3.2 China Gene Editing Service Market Size and Forecast (2017-2028)
8.3.3 Japan Gene Editing Service Market Size and Forecast (2017-2028)
8.3.4 South Korea Gene Editing Service Market Size and Forecast (2017-2028)
8.3.5 India Gene Editing Service Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gene Editing Service Market Size and Forecast (2017-2028)
8.3.7 Australia Gene Editing Service Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Gene Editing Service Revenue by Type (2017-2028)
9.2 South America Gene Editing Service Revenue by Application (2017-2028)
9.3 South America Gene Editing Service Market Size by Country
9.3.1 South America Gene Editing Service Revenue by Country (2017-2028)
9.3.2 Brazil Gene Editing Service Market Size and Forecast (2017-2028)
9.3.3 Argentina Gene Editing Service Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Editing Service Revenue by Type (2017-2028)
10.2 Middle East & Africa Gene Editing Service Revenue by Application (2017-2028)
10.3 Middle East & Africa Gene Editing Service Market Size by Country
10.3.1 Middle East & Africa Gene Editing Service Revenue by Country (2017-2028)
10.3.2 Turkey Gene Editing Service Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gene Editing Service Market Size and Forecast (2017-2028)
10.3.4 UAE Gene Editing Service Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Gene Editing Service Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gene Editing Service Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gene Editing Service Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gene Editing Service Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gene Editing Service Revenue Market Share by Region (2023-2028)
Table 6. Caribou Biosciences Corporate Information, Head Office, and Major Competitors
Table 7. Caribou Biosciences Major Business
Table 8. Caribou Biosciences Gene Editing Service Product and Solutions
Table 9. Caribou Biosciences Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. CRISPR Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. CRISPR Therapeutics Major Business
Table 12. CRISPR Therapeutics Gene Editing Service Product and Solutions
Table 13. CRISPR Therapeutics Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 15. Merck KGaA Major Business
Table 16. Merck KGaA Gene Editing Service Product and Solutions
Table 17. Merck KGaA Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Editas Medicine Corporate Information, Head Office, and Major Competitors
Table 19. Editas Medicine Major Business
Table 20. Editas Medicine Gene Editing Service Product and Solutions
Table 21. Editas Medicine Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific Gene Editing Service Product and Solutions
Table 25. Thermo Fisher Scientific Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 27. Horizon Discovery Major Business
Table 28. Horizon Discovery Gene Editing Service Product and Solutions
Table 29. Horizon Discovery Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Genscript Biotech Corporate Information, Head Office, and Major Competitors
Table 31. Genscript Biotech Major Business
Table 32. Genscript Biotech Gene Editing Service Product and Solutions
Table 33. Genscript Biotech Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. GeneCopoeia Corporate Information, Head Office, and Major Competitors
Table 35. GeneCopoeia Major Business
Table 36. GeneCopoeia Gene Editing Service Product and Solutions
Table 37. GeneCopoeia Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Integrated DNA Technologies Corporate Information, Head Office, and Major Competitors
Table 39. Integrated DNA Technologies Major Business
Table 40. Integrated DNA Technologies Gene Editing Service Product and Solutions
Table 41. Integrated DNA Technologies Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Eurofins Genomics Corporate Information, Head Office, and Major Competitors
Table 43. Eurofins Genomics Major Business
Table 44. Eurofins Genomics Gene Editing Service Product and Solutions
Table 45. Eurofins Genomics Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. DNA 2.0 (ATUM) Corporate Information, Head Office, and Major Competitors
Table 47. DNA 2.0 (ATUM) Major Business
Table 48. DNA 2.0 (ATUM) Gene Editing Service Product and Solutions
Table 49. DNA 2.0 (ATUM) Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. BBI Life Sciences Corporate Information, Head Office, and Major Competitors
Table 51. BBI Life Sciences Major Business
Table 52. BBI Life Sciences Gene Editing Service Product and Solutions
Table 53. BBI Life Sciences Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Genewiz Corporate Information, Head Office, and Major Competitors
Table 55. Genewiz Major Business
Table 56. Genewiz Gene Editing Service Product and Solutions
Table 57. Genewiz Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Gene Oracle Corporate Information, Head Office, and Major Competitors
Table 59. Gene Oracle Major Business
Table 60. Gene Oracle Gene Editing Service Product and Solutions
Table 61. Gene Oracle Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. SBS Genetech Corporate Information, Head Office, and Major Competitors
Table 63. SBS Genetech Major Business
Table 64. SBS Genetech Gene Editing Service Product and Solutions
Table 65. SBS Genetech Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Bio Basic Corporate Information, Head Office, and Major Competitors
Table 67. Bio Basic Major Business
Table 68. Bio Basic Gene Editing Service Product and Solutions
Table 69. Bio Basic Gene Editing Service Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Gene Editing Service Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Gene Editing Service Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Gene Editing Service by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Gene Editing Service Players Head Office, Products and Services Provided
Table 74. Gene Editing Service Mergers & Acquisitions in the Past Five Years
Table 75. Gene Editing Service New Entrants and Expansion Plans
Table 76. Global Gene Editing Service Revenue (USD Million) by Type (2017-2022)
Table 77. Global Gene Editing Service Revenue Share by Type (2017-2022)
Table 78. Global Gene Editing Service Revenue Forecast by Type (2023-2028)
Table 79. Global Gene Editing Service Revenue by Application (2017-2022)
Table 80. Global Gene Editing Service Revenue Forecast by Application (2023-2028)
Table 81. North America Gene Editing Service Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Gene Editing Service Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Gene Editing Service Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Gene Editing Service Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Gene Editing Service Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Gene Editing Service Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Gene Editing Service Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Gene Editing Service Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Gene Editing Service Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Gene Editing Service Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Gene Editing Service Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Gene Editing Service Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Gene Editing Service Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Gene Editing Service Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Gene Editing Service Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Gene Editing Service Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Gene Editing Service Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Gene Editing Service Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Gene Editing Service Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Gene Editing Service Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Gene Editing Service Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Gene Editing Service Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Gene Editing Service Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Gene Editing Service Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Gene Editing Service Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Gene Editing Service Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Gene Editing Service Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Gene Editing Service Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Gene Editing Service Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Gene Editing Service Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Gene Editing Service Picture
Figure 2. Global Gene Editing Service Revenue Market Share by Type in 2021
Figure 3. Ex-Vivo
Figure 4. In-Vivo
Figure 5. Gene Editing Service Revenue Market Share by Application in 2021
Figure 6. Commercial Picture
Figure 7. Academic Research Picture
Figure 8. Global Gene Editing Service Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 9. Global Gene Editing Service Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Gene Editing Service Revenue Market Share by Region (2017-2028)
Figure 11. Global Gene Editing Service Revenue Market Share by Region in 2021
Figure 12. North America Gene Editing Service Revenue (USD Million) and Growth Rate (2017-2028)
Figure 13. Europe Gene Editing Service Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Asia-Pacific Gene Editing Service Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. South America Gene Editing Service Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Middle East and Africa Gene Editing Service Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Gene Editing Service Market Drivers
Figure 18. Gene Editing Service Market Restraints
Figure 19. Gene Editing Service Market Trends
Figure 20. Caribou Biosciences Recent Developments and Future Plans
Figure 21. CRISPR Therapeutics Recent Developments and Future Plans
Figure 22. Merck KGaA Recent Developments and Future Plans
Figure 23. Editas Medicine Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Horizon Discovery Recent Developments and Future Plans
Figure 26. Genscript Biotech Recent Developments and Future Plans
Figure 27. GeneCopoeia Recent Developments and Future Plans
Figure 28. Integrated DNA Technologies Recent Developments and Future Plans
Figure 29. Eurofins Genomics Recent Developments and Future Plans
Figure 30. DNA 2.0 (ATUM) Recent Developments and Future Plans
Figure 31. BBI Life Sciences Recent Developments and Future Plans
Figure 32. Genewiz Recent Developments and Future Plans
Figure 33. Gene Oracle Recent Developments and Future Plans
Figure 34. SBS Genetech Recent Developments and Future Plans
Figure 35. Bio Basic Recent Developments and Future Plans
Figure 36. Global Gene Editing Service Revenue Share by Players in 2021
Figure 37. Gene Editing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Gene Editing Service Revenue Market Share in 2021
Figure 39. Global Top 10 Players Gene Editing Service Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Gene Editing Service Revenue Share by Type in 2021
Figure 42. Global Gene Editing Service Market Share Forecast by Type (2023-2028)
Figure 43. Global Gene Editing Service Revenue Share by Application in 2021
Figure 44. Global Gene Editing Service Market Share Forecast by Application (2023-2028)
Figure 45. North America Gene Editing Service Sales Market Share by Type (2017-2028)
Figure 46. North America Gene Editing Service Sales Market Share by Application (2017-2028)
Figure 47. North America Gene Editing Service Revenue Market Share by Country (2017-2028)
Figure 48. United States Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Gene Editing Service Sales Market Share by Type (2017-2028)
Figure 52. Europe Gene Editing Service Sales Market Share by Application (2017-2028)
Figure 53. Europe Gene Editing Service Revenue Market Share by Country (2017-2028)
Figure 54. Germany Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Gene Editing Service Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Gene Editing Service Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Gene Editing Service Revenue Market Share by Region (2017-2028)
Figure 62. China Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Gene Editing Service Sales Market Share by Type (2017-2028)
Figure 69. South America Gene Editing Service Sales Market Share by Application (2017-2028)
Figure 70. South America Gene Editing Service Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Gene Editing Service Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Gene Editing Service Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Gene Editing Service Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Gene Editing Service Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
